FSGS patients showed greater uPAR immunoexpression compared to patients in control and MCD groups (p = 0.0019; H = 12.57, Dunn ́s post test, Fig 1M to 1P). This evidence concerns the gene PLAUR and focal segmental glomerulosclerosis.